Arm has announced a new CPU variant that could be seen in laptop SoCs. The Arm Cortex-A78C is a variant of the high-end Cortex-A78 that will power the next generation of flagship smartphones. The company had launched the Cortex-A78 in May this year as its most premium Cortex-A CPU, which is claimed to deliver a 20 percent sustained performance upgrade and 50 percent increase in energy savings over last year’s Cortex-A77. While Cortex-A78 cores are almost exclusively earmarked for smartphones, Arm says the new Cortex-A78C will power the next generation of on-the-go devices, such as always-on laptops.Arm made the announcement through a company blog post, which revealed that the new Cortex-A78C will support up to 8 big CPU core clusters for a more “homogenous multi big core computing”. In comparison, Arm’s high-end Cortex-A78 — which is expected to be part of Qualcomm’s Snapdragon 875 and Samsung Exynos 1080 smartphones SoCs — supports 4 big CPU cores and 4 small CPU cores (Cortex-A55) in Arm’s proprietary DynamIQ arrangement.- Advertisement – WWDC 2020 had a lot of exciting announcements from Apple, but which are the best iOS 14 features for India? We discussed this on Orbital, our weekly technology podcast, which you can subscribe to via Apple Podcasts, Google Podcasts, or RSS, download the episode, or just hit the play button below. The company says that the new, more flexible eight-core configuration of the Cortex-A78C can scale up multi-threaded performance that would improve gaming and productivity. Like the Cortex-A78, its new C variant is also compatible with the recently launched Mali-G78 GPU. The new CPU also increases the L3 cache memory to 8MB, which could translate into increased performance especially while working with large datasets, the post says.Arm also says that the new Cortex-A78C CPU enhances data and device security and that its Pointer Authentication Code (PAC) can significantly reduce exploits that allow attackers to take over the software control flow. The company says that it will help in keeping data safe even when installing third-party applications.Arm hasn’t clearly said if its new Cortex-A78C CPU will be a part of SoCs that power laptops or mobile gaming devices anytime soon. If that does happen, it will be interesting to see how the Cortex-A78C on laptop processors level up against the performance of Intel processor cores.- Advertisement – – Advertisement –
Traders work the floor of the New York Stock Exchange.NYSE This is the daily notebook of Mike Santoli, CNBC’s senior markets commentator, with ideas about trends, stocks and market statistics.(This story is for CNBC Pro subscribers only.)A partial reversal of the big reversion trade, the big growth stocks bouncing and flattering the indexes as the majority of stocks catch their breath.Closed bond market means yields can’t tick any higher. This relieves some of the psychological and systematic-trading pressure from the growth complex. The surge in value over growth, small over large, cyclical over defensive had also grown a bit extreme in the short term. – Advertisement – – Advertisement –
Jul 20, 2004 (CIDRAP News) – A woman in Thailand, where avian influenza has resurfaced in the past month, may have the first human case of the illness since the outbreaks earlier in the year, a Bangkok newspaper reported today.An online report by The Nation said a 53-year-old woman in the central province of Lop Buri was hospitalized Jul 14 with symptoms of suspected avian flu, including a heavy cough, high fever, and breathing difficulty. The woman subsequently improved and was out of danger today, the story said.The woman, identified as Jamras Pumthongdee, was among 29 villagers who touched a dead chicken in an area affected by avian flu, the provincial chief public health officer was quoted as saying.In outbreaks last winter and spring, H5N1 avian flu infected 34 people in Thailand and Vietnam, killing 15 Vietnamese and 8 Thais, according to World Health Organization (WHO) figures. All those cases resulted from exposure to poultry, not from person-to-person transmission. But disease experts are concerned that the virus could combine with a human flu virus and acquire the ability to spread from person to person, potentially igniting a flu pandemic.Avian flu has erupted in 13 Thai provinces and in Bangkok in recent weeks, The Nation reported. Yukol Limlaenthong, chief of the Thai government’s livestock department, said about 160,000 birds have been killed in the containment effort, according to the story. A report by Agence France-Presse yesterday said the disease has cropped up in 15 provinces.In Vietnam, small outbreaks of avian flu have occurred in nine central and southern provinces in recent weeks, the Associated Press (AP) reported today. The report said government officials and farmers met in Hanoi today to consider vaccinating poultry against the virus, but did not make a decision.Bui Quang Anh, a Vietnamese veterinary official, said a pilot vaccination program at two farms during the earlier avian flu outbreaks did not work very well, according to the story. It said a Dutch-made vaccine called Intervet was used.Nearly 50,000 birds have been destroyed to contain the outbreaks in Vietnam, the AP reported.In other recent developments, the United Nations Food and Agriculture Organization (FAO) urged authorities in Asia not to kill wild birds in an effort to stop avian flu. In the Jul 16 statement, Juan Lubroth of the FAO Animal Health Service said, “Killing birds will not help to prevent or control avian influenza outbreaks. Wild birds are an important element of the ecosystem and should not be destroyed.”Although some waterfowl can carry avian flu viruses, “there is no scientific evidence that wildlife is the major factor in the resurgence of the disease in the region,” Lubroth said.The FAO said the major factors in the spread of avian flu include “poor hygienic practices” in the poultry industry and individuals’ failure to follow recommended control measures.The WHO issued a statement Jul 16 urging precautions for all workers involved in culling poultry. Workers should receive human flu vaccine and should wear protective clothing, masks, and goggles, the agency said.In addition, health authorities should monitor anyone exposed to infected poultry, and antiviral drugs should be made available to treat anyone with a suspected case of avian flu, according to WHO.See also:Jul 16 FAO statementhttp://www.fao.org/newsroom/en/news/2004/48287/index.htmlJul 16 WHO statementhttp://www.who.int/csr/don/2004_07_16/en/
Jul 19, 2005 (CIDRAP News) – A new study indicates that H5N1 avian influenza viruses are becoming less deadly to ducks, permitting them to carry the viruses for days or weeks and spread them to more susceptible birds and potentially to humans.The findings “suggest that the duck has become the ‘Trojan horse’ of Asian H5N1 influenza viruses,” says the report by an international team led by researchers from St. Jude Children’s Research Hospital in Memphis. “The ducks that are unaffected by infection with these viruses continue to circulate these viruses, presenting a pandemic threat.”The researchers experimentally infected ducks with various H5N1 viruses, most of them dating to 2003 and 2004. About half of the infected ducks survived while shedding the virus for as long as 17 days, according to the report, published online today by the Proceedings of the National Academy of Sciences.Wild waterfowl are the natural hosts for influenza A viruses (including H5N1) and commonly carry them without getting seriously ill. But the report says the biology of H5N1 viruses changed dramatically in late 2002, when they acquired the ability to kill many waterfowl species. Since late 2003, the viruses have spread widely in East and Southeast Asia, killing or forcing the slaughter of tens of millions of chickens and ducks and also infecting more than 100 humans.The investigators, led by senior author Robert G. Webster of St. Jude’s, obtained samples of 14 H5N1 viruses isolated from chickens, ducks, and humans in Vietnam, Hong Kong, Thailand, China, Indonesia, and Singapore. The majority of the samples dated from 2003 or 2004, but a few were from 1997 and 2001.After growing the viruses in chicken eggs, the researchers inoculated each type into two mallard ducks. Two uninfected ducks were added to the cage with the infected ducks 4 hours after inoculation. The ducks were observed for 21 days, and tracheal and cloacal swabs were taken every other day and tested for the virus. Viruses isolated on day 17 were used to inoculate more ducks, and the procedure was repeated.Six of the original set of 14 viruses were found to be highly pathogenic, meaning they killed at least one of the two ducks. All of the viruses were transmitted readily to the uninfected ducks.In previous studies, ducks usually shed highly pathogenic H5N1 viruses in feces for only 2 to 5 days, but in this study the ducks shed the 2003 and 2004 strains for 11 to 17 days. In contrast, 1997 and 2001 versions of the virus were shed for no more than 7 days. A further observation was that the 2003 and 2004 viral strains were shed primarily from the upper respiratory tract rather than in feces.To test whether viruses’ pathogenicity changed during the course of infection, the investigators inoculated uninfected ducks with four viral strains shed by the first set of ducks after 13 and 17 days of infection. Though the original viruses were highly pathogenic, the day-13 and day-17 isolates caused no signs of illness in previously unexposed ducks. However, when chickens were exposed to day-17 isolates of two viruses dating to 2003 and 2004, all of them died.”Our findings suggest a trend toward decreased pathogenicity of H5N1 viruses in ducks, although the small number of viruses and ducks tested (because of space constraints of the biosafety level 3+ facilities) precludes a firm conclusion,” the report says. In view of other evidence that H5N1 viruses isolated from healthy ducks can sicken chickens and mammals, “the duck may be resuming its role as a reservoir of H5N1 viruses, transmitting them to other bird species and potentially to mammals.”The authors add that low-pathogenic H5N1 infection in ducks may be much more common in Asia than is currently suspected. They recommend surveillance of healthy poultry throughout Asia to determine if the virus is endemic in domestic birds and to clarify the role of domestic ducks in its spread.”There is a real possibility that if these H5N1 viruses continue to circulate, further human infection will occur, increasing the potential for human-to-human transmission,” the authors warn.Hulse-Post DJ, Sturm-Ramirez KM, Humberd J, et al. Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci 2005 Jul 26;102(30) [Abstract]
Aug 14, 2006 (CIDRAP News) –The federal government announced today that two swans in Michigan tested positive for both the H5 and N1 avian influenza subtypes, but initial genetic sequencing suggests that it is a low-pathogenic type rather than the highly pathogenic H5N1 strain spreading through birds in Asia, Europe, and Africa and causing deaths in humans.Ron DeHaven, chief veterinary officer for the US Department of Agriculture (USDA), said at a media briefing today that the birds appeared healthy and normal and were part of a group of 20 nonmigratory, resident mute swans that were sacrificed and tested on Aug 8 as part of a population reduction plan at a game area on Lake Erie in southeast Michigan.Bill Raub, science advisor to the secretary of the Department of Health and Human Services, said the findings should not cause alarm. “There is no threat to human health, and there is no cause for any special actions,” he said. “This is a matter of wildlife biology.”On Aug 9 the samples were tested at Michigan State University’s Diagnostic Center for Population and Animal Health, part of the USDA’s National Animal Health Laboratory Network, where tests confirmed the presence of an H5 avian influenza virus. The samples were then sent to the USDA’s National Veterinary Services Laboratory (NVSL) in Ames, Iowa, which is the only national reference laboratory that can confirm the H5N1 virus.Confirmatory tests at the NVSL lab showed the presence of an H5 virus along with an N1 subtype; however, experts aren’t sure if the birds were infected with two separate avian influenza strains or if the findings represent low-pathogenic H5N1. Testing began at the NVSL on Aug 12 to further characterize the virus, and results are expected in about 2 weeks.An analysis of genetic sequences at the NVSL has already suggested that the avian influenza virus in the swans is similar to the low-pathogenic avian flu virus identified previously in North America. Routine sampling in wild ducks in the United States showed evidence of low-pathogenic H5N1 in 1975 and 1986. The virus has also been detected in Canada as recently as 2005.”These results are not unexpected in a given surveillance activity,” DeHaven said at the media briefing.Sue Hazeltine, associate director of biology for the US Geological Survey at the Department of the Interior (DOI), said the agency has taken 8,000 wild bird samples since early June. About 4,000 were from dead birds taken by subsistence hunters in Alaska, and the rest were from live birds. “Less than 2% have shown avian influenza of any type, which is standard and what we would expect to find across the country at any point,” she said. None have tested positive for low-pathogenic H5N1.DeHaven said there is no reason to believe the swans had any connections to any commercial poultry operations, and the findings do not provide a basis for any country to impose any trade restrictions on the United States.On Aug 9 the USDA and the DOI announced they are expanding wild bird monitoring for H5N1 avian influenza beyond Alaska in partnerships with the lower 48 states, Hawaii, and other Pacific islands. Surveillance in Western states in the Pacific flyway during late summer and fall will coincide with the southward migration of birds that have been exposed to Asian species this summer in the Arctic. Surveillance in Alaska has been under way since summer 2005.See also:Transcript of Aug 14 USDA/DOI briefing on Michigan swansAug 14 USDA fact sheet on low pathogenic vs high pathogenic H5N1 avian influenzaDec 20, 2005, CIDRAP News article: ” H5N1 avian flu viruses: What’s in a name?”Aug 10 CIDRAP News article: “US’s wild bird H5N1 monitoring expands beyond Alaska”
Oct 31, 2006 (CIDRAP News) – In a worst-case influenza pandemic, without enough vaccine for everyone, who should stand closer to the front of the line: a 25-year-old water utility worker or a healthy 75-year-old?Public health officials may have to make difficult decisions such as this, and a Minnesota health ethics group, in publishing recommendations about pandemic vaccine allocation, hopes to get conversations going now, rather than during a crisis.The vaccine allocation recommendations released last week by the Minnesota Center for Health Care Ethics (MCHCE) look much different from the ones proposed by the federal government. The vaccine rationing recommendation in federal pandemic plan is aimed at saving the most lives, and might favor the healthy 75-year-old over the 25-year-old utility worker.The Minnesota group’s approach is designed to prevent not only deaths due to influenza, but also deaths related to public infrastructure breakdowns. It is weighted toward those whose immune systems are more likely to respond strongly to a pandemic flu vaccine. As such, it would put the 25-year-old utility worker ahead of the 75-year-old.”The relative priority that the sample plan assigns to different groups offers Minnesotans . . . the maximum chances of surviving both the pandemic and the years immediately thereafter,” the report states.The group said the deadly infrastructure collapse that occurred during the Hurricane Katrina disaster influenced them to seek ways to mitigate other effects of the pandemic, not just the flu deaths. “Seeking only to vaccinate those at high risk of influenza-related mortality leaves them and every other Minnesotan unprotected from death due to breakdowns in basic healthcare, public health, and public safety infrastructures,” the report says.The report emphasizes that approaches to vaccine allocation differ because of different assumptions about pandemic severity. The federal recommendation is based on a moderate pandemic, while the Minnesota group’s plan is based on a severe pandemic, like that of 1918-19, along with an inadequate supply of vaccine.J. Eline Garrett, JD, MCHCE’s assistant director for health policy and public health, told CIDRAP News, “To us, it makes more sense to plan for the worst, then adjust the recommendations if the pandemic isn’t as severe.”The MCHCE’s recommendations assume a W-shaped mortality curve, as seen in the 1918 pandemic, wherein the fatality rate in healthy people aged 15 to 40 is similar to that of small children and elderly people. A more moderate pandemic, like those of 1957 and 1968, has a U-shaped curve, with lowest mortality in young, healthy adults and higher death rates in the youngest and oldest people.According to the MCHCE’s recommendations, those who should receive higher vaccine priority include those with “various combinations” of the following characteristics: high risk for influenza mortality; a strong immune response to vaccination; duty to perform basic healthcare, public health, or public safety roles; a high risk of transmitting the virus to vulnerable groups; or lack of other forms of protection, such as antiviral prophylaxis.The report says people should have a lower priority if any of the following characteristics apply: natural immunity from having survived the pandemic flu, a low risk of death, likelihood of a weak immune response to the vaccine, or access to other acceptable preventive measures.”The sample vaccine rationing plan is expected, in effect, to prioritize healthy adolescents and young adults—especially young adults employed in essential service roles—over elderly persons, infants, and persons with comorbidities,” the report states.Early in a pandemic, the plan would assign top priority to key government leaders and vaccinators, followed by essential workers who are at high risk for flu-related death, are likely to respond well to the vaccine, and have no good alternative.Garrett said singling out who should and shouldn’t receive the vaccine can be controversial. The report has drawn considerable media coverage, and Garrett said some people who e-mailed her were critical of the plan’s focus on immunizing healthy people. “Vaccine allocation is a complex message that doesn’t translate well in a sound bite,” she said.The next step, she said, is to engage the public in discussions about pandemic vaccine allocation.Jason L. Schwartz, MBE, a researcher at the University of Pennsylvania Center for Bioethics, said the Minnesota group’s plan is well reasoned and thoughtful. “Their analysis merits serious consideration,” he said.The federal government, in its pandemic plan, has urged states to take the lead in crafting vaccine allocation strategies, Schwartz said. Though many states mention vaccine distribution in their pandemic plans, few discuss the ethical rationale.Other experts have recently proposed other vaccine allocation approaches. In May, bioethicists from the National Institutes of Health published a report in Science, suggesting a “life-cycle principle” to guide vaccine allocation. The plan would weight vaccine distribution toward those between early adolescence and middle age, in an attempt to consider the amount people have “invested” in their lives and how long they have left to live.Schwartz says he expects that states will take a variety of approaches to vaccine allocation. “That’s not necessarily a bad thing. We all agree with the core guideline about how can we make most efficient use of tools at our disposal,” he said. “We’re seeing different solutions because there are so many unknowns.””If we start wrestling with these issues now, there’s a better chance the public will be supportive,” Schwartz said.The MCHCE is an ethics and health policy consortium sponsored by two Twin Cities healthcare systems along with the Sisters of St. Joseph of Carondelet and the College of St. Catherine in St Paul. The report was produced by members of a multidisciplinary Pandemic Influenza Ethics Work Group to guide Minnesota’s pandemic planning efforts.See also:Minnesota Center for Health Care Ethics recommendations on allocating pandemic influenza vaccines in MinnesotaPubMed abstractUniversity of Pennsylvania Center for Bioethics vaccine ethics Web sitehttp://www.vaccineethics.org/Science article “Who should get influenza vaccine when not all can?”http://www.sciencemag.org/cgi/content/summary/312/5775/854
August 18, 2009Dutch officials set flu vaccine prioritiesHealth authorities in the Netherlands said today they will administer novel flu vaccine starting in October to about 5 million to 6 million people who are at high risk for flu complications, Agence France-Presse reported. Priority groups include those with certain medical conditions, women with underlying conditions who are more than 4 months pregnant, and those older than 60. Officials said they aren’t planning to vaccinate the whole population but have ordered vaccine for 16.5 million people.Canadian experts call for ‘health czar’ to lead flu fightCanada should have a “health czar” to lead a mass immunization campaign against the novel flu virus and streamline the deployment of equipment and staff needed to manage the epidemic, Dr Paul Hebert, editor-in-chief of the Canadian Medical Association Journal, and his team wrote in an editorial yesterday. They said governments need laws that give leaders the power to rapidly respond to complex pandemic issues. He called for a summit to plot out the next public health response actions.Minorities account for oversize share of Boston’s flu hospitalizationsA disproportionate number of patients hospitalized with novel H1N1 flu infections in the Boston area have been African American or Hispanic, the city’s public health officials have found, according to the Boston Globe. They speculate that urban crowding, high levels of chronic health conditions, and other issues related to poverty are contributing factors. Of 71 flu patients hospitalized, 49% were African American and 28% were Hispanic, rates double the groups’ shares of the city population.http://www.boston.com/news/health/articles/2009/08/18/cases_of_swine_flu_higher_among_bostons_blacks_hispanics/?page=2Aug 18 Boston Globe storyChinese firm claims good results in clinical trial of H1N1 vaccineThe Chinese company Sinovac Biotech said a single dose of its novel H1N1 vaccine generated an immune response and appeared safe in its first clinical trial, Bloomberg News reported today. The firm asserted that the product met “international criteria for vaccines” and caused no severe side effects in 1,614 volunteers. The company said the results were the first reported for any H1N1 vaccine clinical trial. No details were released on the immune responses to different doses.Aug 18 Bloomberg storyhttp://www.bloomberg.com/apps/news?pid=20601202&sid=aDT9iV5L1DowMozambique confirms first novel flu caseMozambique’s health ministry today confirmed the country’s first novel flu case, in a 46-year-old woman who had recently traveled to South Africa, AFP reported. She is recovering at home. Meanwhile, a disease expert in South Africa said poverty, diseases such as HIV, and overburdened health systems make African countries vulnerable to the novel flu virus, according to another AFP report today. Ed Rybicki, a virologist, said the virus could spread undetected because of poor disease surveillance.Aug 18 AFP storyCrucell gets NIAID contract for monoclonal antibody workThe Dutch pharmaceutical company Crucell announced today that it received a $40.7 million contract from the National Institute of Allergy and Infectious Diseases to continue developing monoclonal antibodies for the treatment of seasonal and pandemic flu. It contains an option for $28.4 million in additional funding. Crucell said the antibodies are active against seasonal H1N1 viruses, including antiviral-resistant strains, plus H5N1 and pandemic H1N1.http://cws.huginonline.com/C/132631/PR/200908/1335383_5_5.htmlAug 18 Crucell press release
Sep 2, 2009 (CIDRAP News) – Vaccination against the pandemic H1N1 influenza will be required for all uniformed US military personnel, with the immunizations starting in early October, the Department of Defense (DoD) announced yesterday.In a news release, Army Lt. Col. Wayne Hachey, the department’s director of preventive medicine, said vaccination will be mandatory for uniformed personnel and will be available to all military family members who want it.DoD expects to receive 1 million doses of the vaccine in early October and another 1.7 million doses later in the month, the release said.First in line for the vaccine will be healthcare workers, deploying troops, those serving on ships and submarines, and new recruits, according to DoD.”Any place where we take a lot of people, squash them all together and get them nice and close and put them under stressful conditions will get the vaccine,” Hachey said.To distribute the vaccine, he said, the military will use its usual seasonal flu vaccine distribution chain, a system in use for decades.He noted that a decision is still awaited on whether each person will need one dose or two. “The assumption right now is that people will need two doses, 21 days apart. That may change,” he said. Federal officials are awaiting early results of clinical trials for guidance on the number of doses.DoD already has seasonal flu vaccine and will begin giving the immunizations soon, Hachey said. “That has been our message to immunizers: to try and get as many people as they can immunized against the season flu early.”The civilian immunization program for H1N1 is expected to start in mid October.See also:Sep 1 DoD press releasehttp://www.defenselink.mil/news/newsarticle.aspx?id=55698
In the last five years, the Jadranka Group has invested more than 100 million euros in development, which has already resulted in greater recognition of Lošinj’s tourist offer. Contribution to the continuation of this trend will be the realization of further planned investments in the next three to four years, which include projects to expand the Airport Mali Losinj and the construction of Eco Golf Resort Matalda, which represents added value and content and ensures the desired extension of the tourist season. Records in this tourist season are also set by the fifth company in the Croatian hotel industry – the Jadranka Group. The millionth overnight stay this year was realized 10 days earlier than last year, in 2016, which is a confirmation of the excellent results achieved in Jadranka, considering that the season is still going on and guests are still arriving on the islands of Lošinj and Cres.The earlier realization of the millionth overnight stay is not surprising considering that the Lošinj-based Jadranka Group continuously invests in improving the entire 5 * premium offer in Čikat Bay, primarily Hotel Bellevue, Boutique Hotel Alhambra and Villa Hortensie, but also offers at a high 4 * level in Vitality Hotel Punta. Family Hotel Vespera and Hotel Aurora. To this should be added Jadranka camps Baldarin, Slatina, Bijar and camp Čikat, which houses the first aquapark on the islands, which brought him a high 4 *. “Croatian tourism is finally achieving the results it deserves, so everyone in the Jadranka Group is extremely happy to be part of a successful tourism concept. Achieving the millionth overnight stay in the earlier period is an additional recognition of our dedicated work and constant effort to provide our guests with the best and make their stay on Lošinj as pleasant as possible, and the holidays unforgettable.”, Said Goran Filipovic, a member of the Management Board of the Jadranka Group.Jadranka Grupa offers its guests indigenous food from as many as sixty family farms from all over Croatia, primarily from Cres and Lošinj, as well as from Istria, Slavonia and Baranja and Međimurje.The Jadranka Group pays special attention to adjusting its offer to market requirements and guest segmentation, and the great result of such an effective adaptation to complex trends is also evident in the ever earlier realization of the millionth overnight stay. Hotels and villas of the Lošinj Hotels & Villas group, in addition to keeping pace with world trends in tourism and hospitality, are also introducing their own. One of them is the unique collaboration with About 70 family farms throughout Croatia, whose original foods are implemented in the offer, and their availability is a crucial factor in creating daily menus.
After a decade of waiting, Opatija got a facility without which tourist progress cannot be imagined. The Gervais Cultural and Tourist Center was opened, a multifunctional complex intended for all generations and cultural tastes, and the entire investment amounted to HRK 41,5 million. Construction of the center where ‘culture and congresses meet under Učkun’ began in September 2015, on the site of a former Opatija cinema that was demolished to create space for a new building. On the ground floor of the center is a large foyer and a small hall that can accommodate about 300 visitors. On the first floor is the Great Hall with 493 built-in seats intended for more demanding theater and concert productions, cinema screenings and congress events. In the basement there is a club space with a separate entrance that can accommodate about 1000 visitors.With the new Gervais polyvalent center and the Summer Stage, which is often called the ‘pearl of the Mediterranean’ due to its unique architectural identity, symbiosis of greenery and stone and its position on the ‘green peninsula’ of Angiolina Park, we can finally say that culture in Opatija lives on.KC Geravis is an extremely important new space and added value for Opatija for both the cultural and the congress segment.